You have 9 free searches left this month | for more free features.

activated microglia

Showing 1 - 25 of 1,717

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glioblastoma Trial (PET imaging)

Not yet recruiting
  • Glioblastoma
  • PET imaging
  • (no location specified)
Feb 23, 2023

Using IMC to Analyze the Impact of ICANS on Microglia

Recruiting
  • ICANS, Grade Unspecified
  • CAR T-Cell-Related Encephalopathy Syndrome
  • There will be no intervention as we will study patients that undergo autopsy after CAR T cell infusion.
  • Freiburg, Baden Württemberg, Germany
    Freiburg University Medical Center
Apr 12, 2023

Microglia Activation in Asthma

Recruiting
  • Asthma
  • Whole lung antigen challenge (WLAC)
  • [18F]FEPPA
  • Madison, Wisconsin
    University of Wisconsin Madison
Jul 14, 2022

Secondary-progressive Multiple Sclerosis Trial in Buffalo (Mayzent, Ocrevus)

Recruiting
  • Secondary-progressive Multiple Sclerosis
  • Buffalo, New York
    University at Buffalo, Buffalo General Hospital
Oct 10, 2022

Alzheimer Trial in New York (11C-ER176, 18F-florbetaben)

Recruiting
  • Alzheimer Disease
  • New York, New York
    Columbia University Irving Medical Center
Jan 10, 2022

Measuring Active Microglia in Progressive Multiple Sclerosis

Completed
  • Secondary Progressive Multiple Sclerosis
  • [C11]PK-1195 PET scan
  • New York, New York
    Weill Cornell Medical College
Jan 14, 2022

Myocardial Infarction Trial in Birmingham ([18F]DPA-714-PET/MRI)

Recruiting
  • Myocardial Infarction
  • Birmingham, Alabama
    University of Alabama at Birmingham Medical Center
Aug 25, 2022

Microglial Activation inMS Patient Cohort at Risk of Progression

Active, not recruiting
  • Multiple Sclerosis
    • Turku, Finland Proper, Finland
      Turku PET Centre
    May 31, 2022

    X Fragile Syndrome Trial in Malaga (Vitamin C 10mg/Kg Vitamin E 10 mg/Kg, Placebo)

    Completed
    • X Fragile Syndrome
    • Vitamin C 10mg/Kg Vitamin E 10 mg/Kg
    • Placebo
    • Malaga, Málaga, Spain
      Hospital Regional de Málaga
    Jul 21, 2022

    Microglial Activation in the CNS

    Active, not recruiting
    • Multiple Sclerosis
    • Imaging
    • Turku, Finland Proper, Finland
      Turku PET Centre
    May 31, 2022

    Secondary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Salt Lake City

    Recruiting
    • Secondary Progressive Multiple Sclerosis
    • +2 more
    • Ferumoxytol infusion
    • +2 more
    • Salt Lake City, Utah
      University of Utah Health Imaging and Neurosciences Center
    Jun 22, 2022

    Epileptic Seizures Related to Drugs Trial in Xi'an (minocycline)

    Enrolling by invitation
    • Epileptic Seizures Related to Drugs
    • Xi'an, Shaanxi, China
      XijingHospital
    Jul 21, 2023

    Does Microglial Activation Promote Lesion Growth and Progression

    Enrolling by invitation
    • Multiple Sclerosis
      • Turku, Finland Proper, Finland
        Turku PET Centre
      Nov 1, 2022

      Mild Cognitive Impairment, Alzheimer Trial in Worldwide (Canakinumab, Placebo)

      Recruiting
      • Mild Cognitive Impairment
      • Alzheimer Disease
      • Canakinumab
      • Placebo
      • Charlestown, Massachusetts
      • +11 more
      Nov 11, 2022

      Measurement of QSM Signal (Quantitative Susceptibility Mapping)

      Recruiting
      • White Matter Hyperintensity
      • Multiple Sclerosis
      • MRI
      • Paris, France
        Hhopital fondation adolphe de rothschild
      Aug 11, 2022

      Neurotropism and Neuroinflammation in COVID-19 Delirium.

      Recruiting
      • Covid19
      • +2 more
      • serology testing profiles description
      • +4 more
      • Toulouse, France
      • +1 more
      Sep 3, 2021

      Parkinson's Disease Trial in Augusta (Niacin, Niacinamide, Placebo)

      Active, not recruiting
      • Parkinson's Disease
      • Niacin
      • +2 more
      • Augusta, Georgia
        Charlie Norwood VA Medical Center, Augusta, GA
      Mar 8, 2022

      Alzheimer Trial in Paris (Placebo, Masitinib (4.5), Standard of care)

      Not yet recruiting
      • Alzheimer Disease
      • Placebo
      • +2 more
      • Paris, France
        Institut de la mémoire et Maladie d'Alzheimer, Hôpitaux Universi
      Sep 29, 2022

      Schizophrenia Trial in London (Natalizumab, Placebo: normal saline)

      Recruiting
      • Schizophrenia
      • London, United Kingdom
        Institute of Psychiatry, Psychology and Neuroscience, King's Col
      Sep 27, 2022

      Frontotemporal Dementia Trial in London ((18F)-FEPPA)

      Recruiting
      • Frontotemporal Dementia
      • (18F)-FEPPA
      • London, Ontario, Canada
        Parkwood Institute
      Sep 2, 2020

      Critical Asymptomatic Carotid Artery Disease, Non-Critical Asymptomatic Carotid Artery Disease Trial in Birmingham

      Recruiting
      • Critical Asymptomatic Carotid Artery Disease
      • Non-Critical Asymptomatic Carotid Artery Disease
      • Birmingham, Alabama
        UAB
      Dec 13, 2022

      Multiple Sclerosis, Secondary Progressive Trial in Calgary (Hydroxychloroquine Pill, Indapamide Pill)

      Recruiting
      • Multiple Sclerosis, Secondary Progressive
      • Hydroxychloroquine Pill
      • Indapamide Pill
      • Calgary, Alberta, Canada
        Foothills Medical Centre
      May 16, 2022

      Parkinson Disease Trial in Birmingham (DPA-714-PET/MRI)

      Recruiting
      • Parkinson Disease
      • Birmingham, Alabama
        UAB Advanced Imaging Facility
      Mar 29, 2022

      Fibromyalgia, Chronic Fatigue Syndrome, Multiple Sclerosis Trial in Birmingham (DPA-714 PET/MRI)

      Recruiting
      • Fibromyalgia
      • +3 more
      • DPA-714 PET/MRI
      • Birmingham, Alabama
        University of Alabama at Birmingham Medical Center
      Dec 3, 2021

      Intracerebral Hemorrhage, Cerebral Edema, Stroke Hemorrhagic Trial in Winston-Salem (Fingolimod 0.5 mg, Placebo, Standard of

      Recruiting
      • Intracerebral Hemorrhage
      • +4 more
      • Fingolimod 0.5 mg
      • +2 more
      • Winston-Salem, North Carolina
        Wake Forest University Health Sciences
      Nov 28, 2022